213 related articles for article (PubMed ID: 32667913)
1. A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C.
Napolitano F; Merone R; Abbate A; Ammendola V; Horncastle E; Lanzaro F; Esposito M; Contino AM; Sbrocchi R; Sommella A; Duncan JD; Hinds J; Urbanowicz RA; Lahm A; Colloca S; Folgori A; Ball JK; Nicosia A; Wizel B; Capone S; Vitelli A
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008459. PubMed ID: 32667913
[TBL] [Abstract][Full Text] [Related]
2. A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis.
Wang C; Dulal P; Zhou X; Xiang Z; Goharriz H; Banyard A; Green N; Brunner L; Ventura R; Collin N; Draper SJ; Hill AVS; Ashfield R; Fooks AR; Ertl HC; Douglas AD
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006870. PubMed ID: 30372438
[TBL] [Abstract][Full Text] [Related]
3. Protection of non-human primates against rabies with an adenovirus recombinant vaccine.
Xiang ZQ; Greenberg L; Ertl HC; Rupprecht CE
Virology; 2014 Feb; 450-451():243-9. PubMed ID: 24503087
[TBL] [Abstract][Full Text] [Related]
4. A chimpanzee adenoviral vector-based rabies vaccine protects beagle dogs from lethal rabies virus challenge.
Wang X; Fang Z; Xiong J; Yang K; Chi Y; Tang X; Ma L; Zhang R; Deng F; Lan K; Zhou D
Virology; 2019 Oct; 536():32-38. PubMed ID: 31394410
[TBL] [Abstract][Full Text] [Related]
5. Cross-neutralization of antibodies induced by vaccination with Purified Chick Embryo Cell Vaccine (PCECV) against different Lyssavirus species.
Malerczyk C; Freuling C; Gniel D; Giesen A; Selhorst T; Müller T
Hum Vaccin Immunother; 2014; 10(10):2799-804. PubMed ID: 25483634
[TBL] [Abstract][Full Text] [Related]
6. Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product.
Xiang Z; Gao G; Reyes-Sandoval A; Cohen CJ; Li Y; Bergelson JM; Wilson JM; Ertl HC
J Virol; 2002 Mar; 76(6):2667-75. PubMed ID: 11861833
[TBL] [Abstract][Full Text] [Related]
7. A novel mRNA rabies vaccine as a promising candidate for rabies post-exposure prophylaxis protects animals from different rabies viruses.
Yu PC; Dan M; He Y; Meng SL; Yang HY; Su X; Wang YJ; Lv L; Sun YF; Tao XY; Liu Q; Liu SQ; Bi SL; Zhu WY
Microb Pathog; 2023 Dec; 185():106425. PubMed ID: 37923181
[TBL] [Abstract][Full Text] [Related]
8. A chimpanzee-origin adenovirus vector expressing the rabies virus glycoprotein as an oral vaccine against inhalation infection with rabies virus.
Zhou D; Cun A; Li Y; Xiang Z; Ertl HC
Mol Ther; 2006 Nov; 14(5):662-72. PubMed ID: 16797238
[TBL] [Abstract][Full Text] [Related]
9. A recombinant human adenovirus vaccine against rabies.
Prevec L; Campbell JB; Christie BS; Belbeck L; Graham FL
J Infect Dis; 1990 Jan; 161(1):27-30. PubMed ID: 2295855
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of rabies vaccines in dogs and cats and protection in a mouse model against European bat lyssavirus type 2.
Nokireki T; Jakava-Viljanen M; Virtala AM; Sihvonen L
Acta Vet Scand; 2017 Oct; 59(1):64. PubMed ID: 28969696
[TBL] [Abstract][Full Text] [Related]
11. Assessing Rabies Vaccine Protection against a Novel Lyssavirus, Kotalahti Bat Lyssavirus.
Shipley R; Wright E; Lean FZX; Selden D; Horton DL; Fooks AR; Banyard AC
Viruses; 2021 May; 13(5):. PubMed ID: 34065574
[TBL] [Abstract][Full Text] [Related]
12. A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice.
Tian L; Yan L; Zheng W; Lei X; Fu Q; Xue X; Wang X; Xia X; Zheng X
Vet Microbiol; 2021 Jun; 257():109076. PubMed ID: 33957572
[TBL] [Abstract][Full Text] [Related]
13. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.
Xiang ZQ; Yang Y; Wilson JM; Ertl HC
Virology; 1996 May; 219(1):220-7. PubMed ID: 8623532
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH
Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013
[TBL] [Abstract][Full Text] [Related]
15. A novel approach to a rabies vaccine based on a recombinant single-cycle flavivirus vector.
Giel-Moloney M; Rumyantsev AA; David F; Figueiredo M; Feilmeier B; Mebatsion T; Parrington M; Kleanthous H; Pugachev KV
Vaccine; 2017 Dec; 35(49 Pt B):6898-6904. PubMed ID: 28899628
[TBL] [Abstract][Full Text] [Related]
16. Utilisation of Chimeric Lyssaviruses to Assess Vaccine Protection against Highly Divergent Lyssaviruses.
Evans JS; Wu G; Selden D; Buczkowski H; Thorne L; Fooks AR; Banyard AC
Viruses; 2018 Mar; 10(3):. PubMed ID: 29543715
[TBL] [Abstract][Full Text] [Related]
17. Infectivity of attenuated poxvirus vaccine vectors and immunogenicity of a raccoonpox vectored rabies vaccine in the Brazilian Free-tailed bat (Tadarida brasiliensis).
Stading BR; Osorio JE; Velasco-Villa A; Smotherman M; Kingstad-Bakke B; Rocke TE
Vaccine; 2016 Oct; 34(44):5352-5358. PubMed ID: 27650872
[TBL] [Abstract][Full Text] [Related]
18. Development of Novel Vaccines Against Infectious Diseases Based on Chimpanzee Adenoviral Vector.
Zhang C; Chi Y; Zhou D
Methods Mol Biol; 2017; 1581():3-13. PubMed ID: 28374240
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the protective efficacy between single and combination of recombinant adenoviruses expressing complete and truncated glycoprotein, and nucleoprotein of the pathogenic street rabies virus in mice.
Kim HH; Yang DK; Nah JJ; Song JY; Cho IS
Virol J; 2017 Jun; 14(1):122. PubMed ID: 28646885
[TBL] [Abstract][Full Text] [Related]
20. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
